Imatinib mesylate (Gleevec(TM)) reduces phlebotomy requirements in polycythemia vera.
Silver
R T
RT
D000328:Adult; D000368:Aged; D001549:Benzamides; D001792:Blood Platelets / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005260:Female; D006400:Hematocrit; D006801:Humans; D000068877:Imatinib Mesylate; D008297:Male; D008875:Middle Aged; D018962:Phlebotomy; D010879:Piperazines / Q000627:therapeutic use*; D011087:Polycythemia Vera / Q000188:drug therapy* / Q000378:metabolism; D011743:Pyrimidines / Q000627:therapeutic use*
D001549:Benzamides; D004791:Enzyme Inhibitors; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate